Foghorn Therapeutics Inc. (FHTX): Cash & Equivalents
$80.88M
As of 2025-12-31
$68.08M
As of 2026-06-30
+15.7%
3-year compound annual growth
-2.7%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $80.88M | +45.8% | 2026-03-11, Balance as of period end |
| 2024-12-31 | $55.45M | -31.0% | 2026-03-11, Balance as of period end |
| 2023-12-31 | $80.34M | +53.9% | 2025-03-06, Balance as of period end |
| 2022-12-31 | $52.21M | -48.4% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $101.14M | +9.0% | 2023-03-09, Balance as of period end |
| 2020-12-31 | $92.80M | +519.4% | 2022-08-09, Balance as of period end |
| 2019-12-31 | $14.98M | n/a | 2021-03-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $80.88M | +45.8% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $204.99M | +130.8% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $9.02M | +28.4% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $23.02M | +863.4% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $27.14M | +20.8% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $30.15M | -34.9% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $796.8K | -45.9% |
| Celularity Inc (CELU) | 2025-12-31 | $6.17M | +736.7% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $1.77M | -17.7% |
Compare FHTX, VSTM, ZOMDF, BHST side by side · Screen every company in Pharmaceutical Preparations ↗